From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects

从神经到大脑:对人类受试者脊髓刺激的机制理解

基本信息

  • 批准号:
    10518516
  • 负责人:
  • 金额:
    $ 711.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-22 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Spinal cord stimulators (SCS) and related devices are commonly used to treat refractory pain conditions, although mechanisms underlying pain reduction remain unclear. Improved understanding of SCS and the development of biomarkers are critical for improving device design and stimulation patterns and optimizing patient selection for device treatment. The main hypothesis of this proposal is that SCS devices reduce pain by modulating the excitability of peripheral sensory nerve fibers that project within the spinal dorsal columns, and this effect can be leveraged for biomarker development. The rationale for this hypothesis is that first order low-threshold mechanoreceptors project from the periphery through the dorsal column/medial lemniscus system to the brainstem. These are the neurons that (1) have closest proximity to the epidural space, the location of stimulation, and (2) have processes in both the periphery and spinal cord tracts. We will apply specialized tests of peripheral nerve excitability, threshold tracking nerve conduction studies, to detect changes in the excitability exerted on these neurons by SCS. We will also perform secondary measurements to determine other potential mechanisms of SCS in the peripheral and central nervous systems: microneurography, to detect modulation of primary nociceptor neuron excitability; PET-MRI, to measure changes in brain neuroinflammation; plasma cytokines and chemokines, to detect systemic neuroinflammatory effects due to SCS. We will perform sensory phenotyping to identify mechanisms in specific subgroups and pain and psychometric instruments to quantify responses. Aim 1 will use a multiple crossover design in subjects who have stably implanted SCS devices, and SCS settings will be toggled between therapeutic and minimal settings. Crossover intervals will include both two-week periods and rapid two-hour periods between setting changes. Aim 2 will consist of a prospective assessment of subjects prior and after implantation of new SCS devices, with a goal of identifying predictors of pain reduction response. The successful completion of this study will yield new mechanisms by which SCS reduces pain, relevant biomarkers, and further development of promising outcomes for broad pain research.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROY FREEMAN其他文献

ROY FREEMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROY FREEMAN', 18)}}的其他基金

Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus
低血糖、心血管自主神经功能和 2 型糖尿病
  • 批准号:
    8436525
  • 财政年份:
    2013
  • 资助金额:
    $ 711.47万
  • 项目类别:
Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus
低血糖、心血管自主神经功能和 2 型糖尿病
  • 批准号:
    8727092
  • 财政年份:
    2013
  • 资助金额:
    $ 711.47万
  • 项目类别:
Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus
低血糖、心血管自主神经功能和 2 型糖尿病
  • 批准号:
    8885877
  • 财政年份:
    2013
  • 资助金额:
    $ 711.47万
  • 项目类别:
Hypoglycemia, mineralocorticoid receptor and autonomic control
低血糖、盐皮质激素受体和自主控制
  • 批准号:
    8606284
  • 财政年份:
    2011
  • 资助金额:
    $ 711.47万
  • 项目类别:
Hypoglycemia, mineralocorticoid receptor and autonomic control
低血糖、盐皮质激素受体和自主控制
  • 批准号:
    8680352
  • 财政年份:
    2011
  • 资助金额:
    $ 711.47万
  • 项目类别:
Hypoglycemia, mineralocorticoid receptor and autonomic control
低血糖、盐皮质激素受体和自主控制
  • 批准号:
    8327132
  • 财政年份:
    2011
  • 资助金额:
    $ 711.47万
  • 项目类别:
Hypoglycemia, mineralocorticoid receptor and autonomic control
低血糖、盐皮质激素受体和自主控制
  • 批准号:
    8161121
  • 财政年份:
    2011
  • 资助金额:
    $ 711.47万
  • 项目类别:
project 3 - Autonomic Rare Diseases Clinical Research Consortium
项目 3 - 自主神经罕见疾病临床研究联盟
  • 批准号:
    7901213
  • 财政年份:
    2009
  • 资助金额:
    $ 711.47万
  • 项目类别:
THE PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE
直立不耐受的病理生理学
  • 批准号:
    7718901
  • 财政年份:
    2008
  • 资助金额:
    $ 711.47万
  • 项目类别:
THE PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE
直立不耐受的病理生理学
  • 批准号:
    7606947
  • 财政年份:
    2007
  • 资助金额:
    $ 711.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了